|
About the Get Involved category
|
|
0
|
30
|
22 August 2024
|
|
GSK B-United Study
|
|
53
|
2965
|
11 September 2026
|
|
Urgent: Seeking HDV Treatment, Clinical Trial or Bulevirtide Access Options from Uzbekistan
|
|
8
|
164
|
4 September 2026
|
|
Aligos Therapeutics Announces the Completion of Enrollment in the Phase 2 B-SUPREME Study of Pevifoscorvir Sodium Under Development for the Treatment of Chronic HBV Infection
|
|
2
|
252
|
3 August 2026
|
|
World Hepatitis Day event: “Cure for Hepatitis B- hoax, hype, or hope?”
|
|
10
|
432
|
2 August 2026
|
|
Free event: Hear about lived experiences from people in SE Asia/Oceania
|
|
1
|
73
|
2 August 2026
|
|
Precision BioSciences Announces Initial Safety and Antiviral Activity
|
|
45
|
2295
|
2 August 2026
|
|
Joining the PBGENE-HBV (ELIMINATE-B) Phase 1 trial - anyone else? Thoughts on off-target / cancer risks?
|
|
9
|
530
|
21 July 2026
|
|
Green Minds survey
|
|
2
|
128
|
18 July 2026
|
|
2026 NYC Marathon
|
|
7
|
228
|
10 July 2026
|
|
Hep B Lived Experience speakers are needed (Metropolitan Sydney, Australia)
|
|
0
|
89
|
2 July 2026
|
|
Looking for recommendations: Strictly online consults with specialists in HBV functional cures (Bepirovirsen / ASOs)
|
|
3
|
209
|
22 June 2026
|
|
Hep B Quality of Life Survey
|
|
0
|
91
|
17 June 2026
|
|
Https://ir.ionis.com/news-releases/news-release-details/ionis-partner-gsk-announces-bepirovirsen-accepted-priority
|
|
1
|
191
|
10 June 2026
|
|
China approves first-in-class monoclonal antibody for chronic hepatitis D treatment for
|
|
3
|
336
|
6 April 2026
|
|
Hep B Writing Competition now open to everyone in NSW, Australia
|
|
13
|
244
|
16 February 2026
|
|
Lived experience of US funding cuts - please share your story!
|
|
3
|
216
|
14 February 2026
|
|
Confidential online program
|
|
0
|
126
|
7 February 2026
|
|
The 16th Australasian Viral Hepatitis Conference - 12-14 August 2026
|
|
2
|
136
|
6 February 2026
|
|
GSK announces positive data from phase 3 trials and plans to file regulatory approval in the first quarter of 2026
|
|
20
|
1689
|
28 January 2026
|
|
Ausperbio announces AHB-137 Monotherapy achieves 30% functional cure in HBe-negative CHB patients on stable NA therapy
|
|
10
|
625
|
9 January 2026
|
|
Upcoming ACIP Meeting: Public Comments
|
|
42
|
462
|
2 January 2026
|
|
AusperBio Completes Patient Enrollment in Phase III AUSHINE Study of AHB-137 for Chronic Hepatitis B
|
|
0
|
176
|
23 December 2025
|
|
Job opportunities in Australia - Hep B
|
|
1
|
139
|
18 December 2025
|
|
Liver Tumor Article
|
|
10
|
541
|
9 December 2025
|
|
Powerful new DNA editing method raises hopes for cures
|
|
0
|
164
|
4 December 2025
|
|
An RNA interference therapeutic potentially achieves functional cure of chronic hepatitis B virus infection
|
|
2
|
258
|
2 December 2025
|
|
Looking for Aus participants: 30-min paid interview to guide hepatitis D content
|
|
1
|
125
|
26 November 2025
|
|
Patients lived experience to be highlighted in vignettes
|
|
8
|
210
|
14 November 2025
|
|
Update on Study Participation! - Lived Experiences of Young Adults with CHB (US-Based)
|
|
0
|
167
|
14 October 2025
|